Effect of treatment on urinary kidney injury molecule-1 in IgA nephropathy

BMC Nephrology

Volumn 14, Issue 1, 2013, Pages

  Seo, Mi Seon ^a   Park, Moo Yong ^b   Choi, Soo Jeong ^b   Jeon, Jin Seok ^a,b   Noh, Hyunjin ^a,b   Kim, Jin Kuk ^b   Han, Dong Cheol ^a,b   Hwang, Seung Duk ^b   Jin, So Young ^b   Kwon, Soon Hyo ^a,b  

^a Division of Nephrology   (South Korea)

^b Soonchunhyang University College of Medicine   (South Korea)

Author keywords

Biomarker; IgA nephropathy; KIM 1; Treatment in IgA nephropathy reduced the urinary KIM 1 excretion

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMMUNOGLOBULIN A; IMMUNOSUPPRESSIVE AGENT; KIDNEY INJURY MOLECULE 1; BIOLOGICAL MARKER; HAVCR1 PROTEIN, HUMAN; MEMBRANE PROTEIN; VIRUS RECEPTOR;

ADULT; ARTICLE; ATROPHY; BLOOD PRESSURE REGULATION; CLINICAL ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; MALE; PROSPECTIVE STUDY; PROTEINURIA; SODIUM RESTRICTION; TREATMENT DURATION; TREATMENT RESPONSE; URINARY EXCRETION; GLOMERULONEPHRITIS, IGA; MIDDLE AGED; TREATMENT OUTCOME; URINE;

ADULT; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROSPECTIVE STUDIES; RECEPTORS, VIRUS; TREATMENT OUTCOME;

EID: 84880024277     PISSN: None     EISSN: 14712369     Source Type: Journal    
DOI: 10.1186/1471-2369-14-139     Document Type: Article

References (32)

1. IgA nephropathy. Donadio JV, Grande JP, N Engl J Med 2002 347 10 738 748 10.1056/NEJMra020109 12213946 (Pubitemid 35203906)
2. Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies. Li LS, Liu ZH, Kidney Int 2004 66 3 920 923 10.1111/j.1523-1755.2004.00837.x 15327382 (Pubitemid 39120993)
3. Clinical features and natural history in adults with IgA nephropathy. D'Amico G, Am J Kidney Dis 1988 12 5 353 357 3055956
4. IgA nephropathy: prognostic classification of end-stage renal failure. L'Association des Nephrologues de l'Est. Frimat L, Briancon S, Hestin D, Aymard B, Renoult E, Huu TC, Kessler M, Nephrol Dial Transplant Offic Publ Eur Dial Transpl Assoc Eur Renal Assoc 1997 12 12 2569 2575 (Pubitemid 27520676)
5. Predicting renal outcome in IgA nephropathy. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP, J Am Soc Nephrol 1997 8 2 199 207 9048338 (Pubitemid 127455874)
6. Predicting progression in IgA nephropathy. Bartosik LP, Lajoie G, Sugar L, Cattran DC, Am J Kidney Dis 2001 38 4 728 735 10.1053/ajkd.2001.27689 11576875 (Pubitemid 33666517)
7. Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury. Han WK, Bailly V, Abichandani R, Thadhani R, Bonventre JV, Kidney Int 2002 62 1 237 244 10.1046/j.1523-1755.2002.00433.x 12081583 (Pubitemid 34754067)
8. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Vaidya VS, Ramirez V, Ichimura T, Bobadilla NA, Bonventre JV, Am J Physiol Renal Physiol 2006 290 2 517 F529 10.1152/ajprenal.00291.2005 16174863 (Pubitemid 43725006)
9. Tubular kidney injury molecule-1 in protein-overload nephropathy. van Timmeren MM, Bakker SJ, Vaidya VS, Bailly V, Schuurs TA, Damman J, Stegeman CA, Bonventre JV, van Goor H, Am J Physiol Renal Physiol 2006 291 2 456 F464 10.1152/ajprenal.00403.2005 16467126 (Pubitemid 44148135)
10. Tubular kidney injury molecule-1 (KIM-1) in human renal disease. van Timmeren MM, van den Heuvel MC, Bailly V, Bakker SJ, van Goor H, Stegeman CA, J Pathol 2007 212 2 209 217 10.1002/path.2175 17471468 (Pubitemid 46852099)
11. High urinary excretion of kidney injury molecule-1 is an independent predictor of graft loss in renal transplant recipients. van Timmeren MM, Vaidya VS, van Ree RM, Oterdoom LH, de Vries AP, Gans RO, van Goor H, Stegeman CA, Bonventre JV, Bakker SJ, Transplantation 2007 84 12 1625 1630 10.1097/01.tp.0000295982.78039.ef 18165774
12. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy. Peters HP, Waanders F, Meijer E, van den Brand J, Steenbergen EJ, van Goor H, Wetzels JF, Nephrol Dial Transpl Offic Publ Eur Dial Transpl Assoc Eur Renal Assoc 2011 26 11 3581 3588
13. Urinary kidney injury molecule-1 in patients with IgA nephropathy is closely associated with disease severity. Xu PC, Zhang JJ, Chen M, Lv JC, Liu G, Zou WZ, Zhang H, Zhao MH, Nephrol Dial Transplant Offic Publ Eur Dial Transpl Assoc Eur Renal Assoc 2011 26 10 3229 3236
14. KIM-1 expression predicts renal outcomes in IgA nephropathy. Kwon SH, Park MY, Jeon JS, Noh H, Choi SJ, Kim JK, Hwang SD, Jin SY, Han DC, Clin Exp Nephrol 2013 17 3 359 364 10.1007/s10157-012-0707-2 23135864
15. The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S, Alpers CE, Amore A, Working Group of the International Ig ANN, the Renal Pathology S, et al. Kidney Int 2009 76 5 534 545 10.1038/ki.2009.243 19571791
16. Predictors of outcome in paediatric IgA nephropathy with regard to clinical and histopathological variables (Oxford classification). Edstrom Halling S, Soderberg MP, Berg UB, Nephrol Dial Transplant Offic Publ Eur Dial Transpl Assoc Eur Renal Assoc 2012 27 2 715 722
17. Histopathologic features aid in predicting risk for progression of IgA nephropathy. Walsh M, Sar A, Lee D, Yilmaz S, Benediktsson H, Manns B, Hemmelgarn B, Clin J Am Soc Nephrol 2010 5 3 425 430 10.2215/CJN.06530909 20089495
18. The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Roberts IS, Cook HT, Troyanov S, Alpers CE, Amore A, Barratt J, Berthoux F, Bonsib S, Bruijn JA, Cattran DC, et al. Kidney Int 2009 76 5 546 556 10.1038/ki.2009.168 19571790
19. Validation of the oxford classification of IgA nephropathy: a single-center study in korean adults. Lee H, Yi SH, Seo MS, Hyun JN, Jeon JS, Noh H, Han DC, Hwang SD, Jin SY, Kwon SH, Korean J Intern Med 2012 27 3 293 300 10.3904/kjim.2012.27.3.293 23019394
20. Effect of renin-angiotensin-aldosterone system inhibition, dietary sodium restriction, and/or diuretics on urinary kidney injury molecule 1 excretion in nondiabetic proteinuric kidney disease: a post hoc analysis of a randomized controlled trial. Waanders F, Vaidya VS, van Goor H, Leuvenink H, Damman K, Hamming I, Bonventre JV, Vogt L, Navis G, Am J Kidney Dis 2009 53 1 16 25 10.1053/j.ajkd.2008.07.021 18823687
21. Reduction of proteinuria in adriamycin-induced nephropathy is associated with reduction of renal kidney injury molecule (Kim-1) over time. Kramer AB, van Timmeren MM, Schuurs TA, Vaidya VS, Bonventre JV, van Goor H, Navis G, Am J Physiol Renal Physiol 2009 296 5 1136 F1145 10.1152/ajprenal.00541.2007 19225054
22. Pathological regression by angiotensin II type 1 receptor blockade in patients with mesangial proliferative glomerulonephritis. Ohtake T, Oka M, Maesato K, Mano T, Ikee R, Moriya H, Kobayashi S, Hypertens Res 2008 31 3 387 394 10.1291/hypres.31.387 18497456 (Pubitemid 351597490)
23. Reversal of glomerulosclerosis after high-dose enalapril treatment in subtotally nephrectomized rats. Adamczak M, Gross ML, Krtil J, Koch A, Tyralla K, Amann K, Ritz E, J Am Soc Nephrol 2003 14 11 2833 2842 10.1097/01.ASN. 0000095248.91994.D3 14569093 (Pubitemid 37305646)
24. An extremely high dose of losartan affords superior renoprotection in the remnant model. Fujihara CK, Velho M, Malheiros DM, Zatz R, Kidney Int 2005 67 5 1913 1924 10.1111/j.1523-1755.2005.00290.x 15840039 (Pubitemid 40577727)
25. Peritubular ischemia contributes more to tubular damage than proteinuria in immune-mediated glomerulonephritis. Wong MG, Suzuki Y, Tanifuji C, Akiba H, Okumura K, Sugaya T, Yamamoto T, Horikoshi S, Tan SY, Pollock C, et al. J Am Soc Nephrol 2008 19 2 290 297 10.1681/ASN.2007020226 18094368 (Pubitemid 351240651)
26. Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase. de Borst MH, van Timmeren MM, Vaidya VS, de Boer RA, van Dalen MB, Kramer AB, Schuurs TA, Bonventre JV, Navis G, van Goor H, Am J Physiol Renal Physiol 2007 292 1 313 F320 16896183
27. Protein overload stimulates RANTES production by proximal tubular cells depending on NF-kappa B activation. Zoja C, Donadelli R, Colleoni S, Figliuzzi M, Bonazzola S, Morigi M, Remuzzi G, Kidney Int 1998 53 6 1608 1615 10.1046/j.1523-1755.1998.00905.x 9607191 (Pubitemid 28243743)
28. Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. Ichimura T, Bonventre JV, Bailly V, Wei H, Hession CA, Cate RL, Sanicola M, J Biol Chem 1998 273 7 4135 4142 10.1074/jbc.273.7.4135 9461608 (Pubitemid 28103282)
29. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Ichimura T, Hung CC, Yang SA, Stevens JL, Bonventre JV, Am J Physiol Renal Physiol 2004 286 3 552 F563 10.1152/ajprenal.00285.2002 14600030
30. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. Donadio JV, Bergstralh EJ, Grande JP, Rademcher DM, Nephrol Dial Transplant Offic Publ Eur Dial Transpl Assoc Eur Renal Assoc 2002 17 7 1197 1203 (Pubitemid 34812063)
31. Remission of proteinuria improves prognosis in IgA nephropathy. Reich HN, Troyanov S, Scholey JW, Cattran DC, J Am Soc Nephrol 2007 18 12 3177 3183 10.1681/ASN.2007050526 17978307 (Pubitemid 350223978)
32. Kidney injury molecule-1 expression in murine polycystic kidney disease. Kuehn EW, Park KM, Somlo S, Bonventre JV, Am J Physiol Renal Physiol 2002 283 6 1326 F1336 12388382